Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A Pfizer Drug Moves Closer to Approval in Another Important Indication
A Pfizer Drug Moves Closer to Approval in Another Important Indication
A Pfizer Drug Moves Closer to Approval in Another Important Indication
Submitted by
admin
on November 3, 2021 - 10:38am
Source:
Motley Fool
News Tags:
Cibingo
Pfizer
Europe
eczema
atopic dermatitis
Headline:
A Pfizer Drug Moves Closer to Approval in Another Important Indication
snippet:
Cibinqo could be just months away from receiving regulatory approval in the EU.
The drug could haul in $600 million annually for Pfizer in the EU.
Pfizer's steady 3.6% yield makes it a great stock for income investors.
Do Not Allow Advertisers to Use My Personal information
